Earnings Scheduled For August 4, 2021
Companies Reporting Before The Bell
• UroGen Pharma (NASDAQ:URGN) is projected to report earnings for its second quarter.
Morgan Stanley’s Top Oil & Gas Plays Ahead Of Q2 Earnings
Despite a recent sector sell-off in oil and gas, a Morgan Stanley analyst cites a "consistent execution on spending" and strong excess cash flow usage "towards capital returns and debt reduction" as reasons to remain favorable.
Analyst Ratings For APA
APA (NASDAQ:APA) has observed the following analyst ratings within the last quarter:
Last 30 Days
1 Month Ago
2 Months Ago
Keybanc Maintains Overweight on APA, Lowers Price Target to $25
Keybanc analyst Leo Mariani maintains APA (NASDAQ:APA) with a Overweight and lowers the price target from $26 to $25.
Analyzing APA’s Unusual Options Activity
Shares of APA (NASDAQ:APA) saw some unusual options activity on Monday. Following the unusual option alert, the stock price moved down to $17.2.
Unusual Options Activity Insight: APA
APA (NASDAQ:APA) shares experienced unusual options activity on Friday. The stock price moved down to $18.11 following the option alert.
Energy Stocks May Be In Focus As Oil Rises After OPEC+ Doesn’t Agree On Output Increases
Now that the fireworks have fired and the flags are furled, it’s time to get back to the business of business and markets.
JP Morgan Downgrades APA to Neutral, Announces $27 Price Target
JP Morgan analyst Arun Jayaram downgrades APA (NASDAQ:APA) from Overweight to Neutral and announces $27 price target.
Bernstein Upgrades APA to Outperform, Raises Price Target to $35
Bernstein analyst Bob Brackett upgrades APA (NASDAQ:APA) from Market Perform to Outperform and raises the price target from $23 to $35.